Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2003
12/11/2003US20030229044 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
12/11/2003US20030229008 Regenerating organs; anticancer agents; autoimmune disease; stabilization cells
12/11/2003US20030228365 Pharmaceutical formulation
12/11/2003US20030228359 Antiallergen mixture
12/11/2003US20030228355 Precipitation of lipid; fineness particle size
12/11/2003US20030228281 Use of mutant herpes viruses and anticancer agents in the treatment of cancer
12/11/2003US20030228278 Immunotherapy of chronic infections and of malignant diseases
12/11/2003CA2488270A1 Paramyxoviral vectors encoding antibodies, and uses thereof
12/11/2003CA2487932A1 Cd16a binding proteins and use for the treatment of immune disorders
12/11/2003CA2487915A1 Allergen from mugwort pollen
12/11/2003CA2487904A1 Immunostimulatory oligonucleotides and uses thereof
12/11/2003CA2487688A1 Piperidine derivative, process for producing the same, and use
12/11/2003CA2487679A1 Inhibitors of jak and cdk2 protein kinases
12/11/2003CA2487171A1 Method for the protection of endothelial and epithelial cells during chemotherapy
12/11/2003CA2486174A1 Xanthine phosphodiesterase v inhibitor polymorphs
12/11/2003CA2484451A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003CA2482838A1 Pyrazole compounds and pharmaceutical compositions containing the compound
12/11/2003CA2482639A1 3-substituted quinuclidines and their use
12/11/2003CA2454654A1 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
12/10/2003EP1369489A1 Flavonoid compound and process for producing the same
12/10/2003EP1369483A1 Allergen from mugwort pollen
12/10/2003EP1369428A1 Muc-1 derivatives and their use in treating cancer-associated MUC-1 Mucin-induced immunosuppression
12/10/2003EP1369409A1 Process for preparing compounds useful as intermediates
12/10/2003EP1369127A1 Novel medicinal use of aplpha antigen or alpha antigen gene
12/10/2003EP1369119A1 Il-12 expression controlling agents
12/10/2003EP1369114A1 Use of tryptophan metabolites as pharmaceutical agents
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368459A2 Influenza viruses with enhanced transcriptional and replicational capacities
12/10/2003EP1368458A2 Interferon-alpha induced gene
12/10/2003EP1368457A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368377A2 Modified interferon beta with reduced immunogenicity
12/10/2003EP1368372A2 Peptides having affinity for the gp120 viral protein and use thereof
12/10/2003EP1368355A2 Substituted pyrazolopyrimidines and thiazolopyrimidines
12/10/2003EP1368354A1 Modulators of chemokine receptor activity
12/10/2003EP1368349A1 Xanthine derivative, production and use thereof as a medicament
12/10/2003EP1368345A1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists
12/10/2003EP1368317A1 Tryptase inhibitors
12/10/2003EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators
12/10/2003EP1368313A1 Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368306A1 Novel 1,2-diphenylethene derivatives for treatment of immune diseases
12/10/2003EP1368253A1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
12/10/2003EP1368094A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
12/10/2003EP1368057A2 Method to enhance the immunogenicity of an antigen
12/10/2003EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
12/10/2003EP1368044A2 Immunomodulator for the management of human immunodeficiency virus (hiv) disease/infection
12/10/2003EP1368037A2 Estrogen replacement therapy
12/10/2003EP1368028A1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
12/10/2003EP1368018A2 Use of sugar phosphate, sugar phosphate analogues, amino acids and/or amino acid analogues for modulating the glycolysis-enzyme complex, the malate-aspartate shuttle and/or transaminases
12/10/2003EP1368015A1 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function
12/10/2003EP1367999A2 Water soluble and palatable complexes
12/10/2003EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
12/10/2003EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1284263B1 Derivatives of p- hydroxy phenyl propionic acid as antiproliferative agents
12/10/2003EP1163243B1 Calanolides for inhibiting btk
12/10/2003EP1066058B1 Immunotoxin cocktails for the treatment of immune related diseases
12/10/2003EP1049711B1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
12/10/2003EP0996726B1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS
12/10/2003EP0932618B1 Peptide analogues containing a 7-membered lactam ring
12/10/2003EP0901374B1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
12/10/2003EP0724456B1 Antibodies to cd40
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003EP0502892B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
12/10/2003CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using
12/10/2003CN1461308A Leucine-based motif and clostridial neurotoxins
12/10/2003CN1461304A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461303A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461299A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461297A Suplatast tosilate crystals
12/10/2003CN1461214A Compositions for improving skin environment and clothes thereof
12/10/2003CN1460522A Egg yolk antibody composite for preventing and curing diseases and its preparaion method
12/10/2003CN1460494A Liquid medicine for external application for making foot therapy
12/10/2003CN1460487A Propolis soft capsule and its preparation method
12/10/2003CN1130372C 肽衍生物 Peptide derivatives
12/10/2003CN1130349C H3 receptor liqands of phenyl-alkyl-imidazoles type
12/10/2003CN1130215C Medicine for curing immunologic disease
12/10/2003CN1130214C Medicine for treating purpura caused by lupus erythematosus and other immunological disease
12/10/2003CA2389911A1 Broad spectruma antagonists and vaccines directed against pyrogenic exotoxins
12/09/2003US6660891 Methods for the production of D-chiro-inositol and the use of D-chiro inositol obtained therefrom
12/09/2003US6660862 Genetic engineering
12/09/2003US6660848 Signal Transducer and Activator of Transcription (STAT) proteins are a new class of intracellular transcription factors
12/09/2003US6660843 Fusion of Fc domains with biologically active peptides
12/09/2003US6660839 Tumor necrosis related receptor, TR7
12/09/2003US6660747 Amido ether substituted imidazoquinolines
12/09/2003US6660744 Pyrazolopyrimidines as therapeutic agents
12/09/2003US6660738 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction
12/09/2003US6660735 Urea substituted imidazoquinoline ethers
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003US6660723 Activating primate gamma delta lymphocytes
12/09/2003US6660722 Therapeutical treatments
12/09/2003US6660520 Nrde
12/09/2003US6660495 Tolerogenic fragments of natural allergens
12/09/2003US6660268 Proteasome regulation of NF-KB activity
12/09/2003US6660266 Ligating agent comprises (i) at least two IgG Fc regions or (ii) a multivalent antibody which binds to Fe gamma I receptor.
12/09/2003US6660261 Bordetella strain expressing the FHA hybrid, liposomes and vaccines
12/09/2003CA2387284C Chinese herbs extract
1 ... 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 ... 1172